Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Rallybio adds Helen Boudreau to Board

Rallybio has appointed Helen M. Boudreau, former Chief Operating Officer of the Bill & Melinda Gates Medical Research Institute, to its Board of Directors. Ms....

| By Kelley Gipson

Sema4 now hiring as they scale up

Sema4 is looking for stellar talent as they scale up to advance their mission of transforming healthcare. 40+ IMMEDIATE positions, including Laboratory Technicians, now open...

| By Kelley Gipson

InveniAI and Prism to develop gut-related therapies

InveniAI will collaborate with PRISM BioLab to build a pipeline of novel therapeutic candidates addressing diseases in the gut associated with the dysfunction of the gut-brain-axis and...

| By Kelley Gipson

Biorez raises $3.5 million in seed financing

Biorez has raised $3.5 million in its Series Seed financing, adding to $3.5 million raised previously. The financing round included participation from Connecticut Innovations. Based...

| By Kelley Gipson

Pfizer continues progress on COVID-19 vaccine

Pfizer and its partner BioNTech have five potential COVID-19 vaccines in clinical trials, each of which is based on a different mRNA format. Now the...

| By Kelley Gipson

Pfizer continues progress on COVID-19 vaccine

Pfizer and its partner BioNTech have five potential COVID-19 vaccines in clinical trials, each of which is based on a different mRNA format. Now the...

| By Kelley Gipson

Women In Bio to launch CT executive program 9/23

Women In Bio has launched an Executive Women In Bio (EWIB) cohort in Connecticut. This group was co-founded by Rebecca Velez Frey Pharm.D., COO EvolveImmune Therapeutics...

| By Kelley Gipson

Yale wastewater sampling used to predict COVID-19

Yale’s wastewater sampling project – an effort to predict outbreaks of COVID-19 in communities – has expanded to several locations in Connecticut. Yale researchers have...